PM(NOC) Regulations Amendments

Price: $95.00

Member Price: $75.00

Add to Cart

Held on November 30, 2017

Significant changes to Patented Medicines (Notice of Compliance) Regulations came into force on September 21, 2017. Pursuant to obligations under CETA, to end dual litigation and provide a right of appeal, these amendments will have a major impact on the courts and those who litigate pharmaceutical patents in Canada.

In this webinar, expert patent litigators will examine the new Regulations' substantive and procedural changes affecting both brand and generic sides of the pharmaceutical industry.


Carol Hitchman Sprigings Intellectual Property Law

Yael Bienenstock Torys LLP


Paul Lomic Lomic Law

Continuing Professional Development

This program is eligible for up to 1 Substantive Hour.

If you wish to receive CPD accreditation for this webinar please write to when you have completed viewing the recording. Please provide the CPD code as provided in the recording.


1 hr

Law Society of Upper Canada

Barreau du Québec

Law Society of British Columbia

Law Society of Saskatchewan

upon request

Law Society of Manitoba

Law Society of Alberta

New York CLE Board